Zymeworks to hold annual meeting on Dec 15, 2026
- Annual meeting on Dec 15, 2026
- Vote on director elections and executive compensation
- Proxy materials available online starting Oct 16, 2026
ZYME
Zymeworks Inc. SEC filings
Every EDGAR filing for Zymeworks Inc. (ZYME), newest first, with AI summaries and stories.
- Ticker
- ZYME
- CIK
- 1937653
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 open-market sale ($358K), 1 grant or exercise.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEPRE 14AZymeworks Inc.ZYMELIVE ROUTINE4Zymeworks Inc.ZYMELIVE ZYME: Executive sells shares
- 10/09/2026: 13,832 shares sold
- 37,037 shares acquired via RSU vesting
- Price range: $25.85-$25.88
Adam Schayowitz, reporting
ROUTINE144Zymeworks Inc.ZYMELIVE ZYME: Schayowitz files Form 144
- Filer: Adam Schayowitz
- Securities: 13832 common shares
- Date: 10/09/2026
Adam Schayowitz, reporting
ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINE8-KZymeworks Inc.ZYMELIVE NOTABLE10-QZymeworks Inc.ZYMELIVE ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINE4Zymeworks Inc.ZYMELIVE Mark Hollywood, insider filing for ZYME
Mark Hollywood, reporting
ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINE4Zymeworks Inc.ZYMELIVE 2 insider filings
Paul R Schneider, insider filing for ZYME
Show all 2
- 4Insider filing for ZYME
- 3New insider at ZYME
Paul R Schneider, reporting
ROUTINESCHEDULE 13G/AZymeworks Inc.ZYMELIVE Ownership stake disclosure by Rubric Capital Management LP (amended)
Rubric Capital Management LP, filed by
ROUTINE8-KZymeworks Inc.ZYMELIVE NOTABLE10-QZymeworks Inc.ZYMELIVE ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINESCHEDULE 13GZymeworks Inc.ZYMELIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC, filed by
ROUTINE4Zymeworks Inc.ZYMELIVE 4 insider filings
Adam Schayowitz, insider filing for ZYME
Show all 4
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 3New insider at ZYME
- 3New insider at ZYME
Adam Schayowitz, reporting
ROUTINE4Zymeworks Inc.ZYMELIVE 2 insider filings
Kristin Stafford, insider filing for ZYME
Show all 2
- 4Insider filing for ZYME
- 3New insider at ZYME
Kristin Stafford, reporting
ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINE144Zymeworks Inc.ZYMELIVE Jeffrey T L Smith, planned sale of ZYME shares
Jeffrey T L Smith, reporting
ROUTINES-8Zymeworks Inc.ZYMELIVE ROUTINE8-KZymeworks Inc.ZYMELIVE NOTABLE10-KZymeworks Inc.ZYMELIVE ROUTINE8-KZymeworks Inc.ZYMELIVE ROUTINE144Zymeworks Inc.ZYMELIVE Leone D Patterson, planned sale of ZYME shares
Leone D Patterson, reporting
ROUTINE144Zymeworks Inc.ZYMELIVE Leone D Patterson, planned sale of ZYME shares
Leone D Patterson, reporting
ROUTINESCHEDULE 13G/AZymeworks Inc.ZYMELIVE Ownership stake disclosure by Rubric Capital Management LP (amended)
Rubric Capital Management LP, filed by
ROUTINESCHEDULE 13G/AZymeworks Inc.ZYMELIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
ROUTINE3Zymeworks Inc.ZYMELIVE Sabeen Mekan, new insider at ZYME
Sabeen Mekan, reporting
ROUTINE4Zymeworks Inc.ZYMELIVE 4 insider filings
Mark Hollywood, insider filing for ZYME
Show all 4
- 4Insider filing for ZYME
- 3New insider at ZYME
- 4Insider filing for ZYME
- 3New insider at ZYME
Mark Hollywood, reporting
ROUTINE4Zymeworks Inc.ZYMELIVE 8 insider filings
Jeffrey T L Smith, insider filing for ZYME
Show all 8
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
- 4Insider filing for ZYME
Jeffrey T L Smith, reporting
ROUTINE4Zymeworks Inc.ZYMELIVE Kenneth Galbraith, insider filing for ZYME
Kenneth Galbraith, reporting
ROUTINE144Zymeworks Inc.ZYMELIVE 4 Form 144 notices
Kenneth Galbraith, planned sale of ZYME shares
Show all 4
- 144Planned insider sale of ZYME shares
- 144Planned insider sale of ZYME shares
- 144Planned insider sale of ZYME shares
- 144Planned insider sale of ZYME shares
Kenneth Galbraith, reporting